.
MergerLinks Header Logo

New Deal


Announced

Ally Bridge Group and Sofinnova Partners led a $108m investment in Mainstay.

Financials

Edit Data
Transaction Value£77m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Ireland

medical devices

Private Equity

Private

Minority

Medical Equipment

Cross Border

Friendly

Completed

Synopsis

Edit

Ally Bridge Group and Sofinnova Partners led a $108m investment in Mainstay, an independent residential property asset management provider. Additional investors include KCK Group and Fountain Healthcare Partners. “A financing of this magnitude, supported by such a quality global investor group, is testament to the confidence in the commercial opportunity for ReActiv8. We are now strongly capitalized to execute on our corporate objectives in 2021 and beyond, including the launch of ReActiv8 in the US market and acceleration of our commercialization efforts in Europe and Australia," Jason Hannon, Mainstay CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US